Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis

Digestive Diseases and Sciences

Volumn 41, Issue 9, 1996, Pages 1733-1740

  Czaja, Albert J ^a   Pfeifer, Karin D ^b   Decker, Richard H ^b   Vallari, Ana S ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Asialoglycoprotein receptor; Autoantibodies; Autoimmune hepatitis

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNITY; FEMALE; HEPATITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029738908     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02088738     Document Type: Article

References (42)

1. Czaja AJ: Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis 4:1-12, 1984
2. Czaja AJ: Autoimmune hepatitis: Evolving concepts and treatment strategies. Dig Dis Sei 40:435-456, 1995
3. Johnson PJ, McFarlane IG, Alvarez F, Bianchi FB, Bianchi L, Burroughs A, Chapman RW, Czaja AJ, Desmet V, Eddleston ALWF, Gerber MA, Hoofnagle JH, Kakumu S, MacSween RNM, Maddrey WC, Manns MP, Meyer zum Buschenfelde K-H, Mieli-Vergani G, Portmann BC, Reed WD, Schalm SW, Scheuer PJ, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M: Meeting report. International Autoimmune Hepatitis Group. Hepatology 18:998-1005, 1993
4. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1513-1520, 1994
5. International Working Party: Terminology of chronic hepatitis. Am J Gastroenterol 90:181-189, 1995
6. Czaja AJ: Autoimmune chronic active hepatitis-a specific entity? The negative argument. J Gastro-Hepatol 5:343-351, 1990
7. Czaja AJ: Chronic active hepatitis: The challenge for a new nomenclature. Ann Intern Med 119:510-517, 1993
8. Czaja AJ, Manns MP: The validity and importance of subtypes of autoimmune hepatitis: A point of view. Am J Gastroenterol 90:1206-1211, 1995
9. Homberg J-C, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, Darnis F, Levy V-G, Grippon P, Opolon P, Bernuau J, Benhamou J-P, Alagille D: Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of "autoimmune" hepatitis. Hepatology 7:1333-1339, 1987
10. Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Buschenfelde K-H: Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1:292-294, 1987
11. Stechemesser E, Klein R, Berg PA: Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology 18:1-9, 1993
12. Czaja AJ, Carpenter HA, Manns MP: Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology 105:1522-1528, 1993
13. Czaja AJ, Manns MP, Homburger HA: Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 103:1290-1295, 1992
14. Czaja AJ, Davis GL, Ludwig J, Baggenstoss AH, Taswell HF: Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology. Gastroenterology 85:713-717, 1983
15. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 108:157-164, 1995
16. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovsky HL: High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21:613-619, 1995
17. Tan EM, Chan EKL, Sullivan KF, Rubin RL: Antinuclear antibodies (ANAs): Diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 47:121-141, 1988
18. Tan EM: Antinuclear antibodies. Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93-151, 1989
19. Toh B-H: Smooth muscle autoantibody and autoantigens. Clin Exp Immunol 38:621-628, 1979
20. Czaja AJ, Nishioka M, Morshed SA, Hachiya T: Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 107:200-207, 1994
21. Czaja AJ, Ming C, Shirai M, Nishioka M: Frequency and significance of antibodies to histories in autoimmune hepatitis. J Hepatol 23:32-38, 1995
22. Dighiero O, Lymberi P, Monot C, Abuaf N: Sera with high levels of anti-smooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeletal proteins. Clin Exp Immunol 82:52-56, 1990
23. Treichel U, Poralla T, Hess G, Manns M, Meyer zum Buschenfelde K-H: Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis. Hepatology 11:606-612, 1990
24. Poralla T, Treichel U, Lohr H, Fleischer B: The asialoglycoprotein receptor as target structure in autoimmune liver diseases. Semin Liver Dis 11:215-222, 1991
25. Treichel U, Gerken G, Rossol S, Rotthauwe HW, Meyer zum Buschenfelde K-H, Poralla T: Autoantibodies against the human asialoglycoprotein receptor: Effects of therapy in autoimmune and virus-induced chronic active hepatitis. J Hepatol 19:55-63, 1993
26. Treichel U, McFarlane BM, Seki T, Krawitt EL, Alessi N, Stickel F, McFarlane IG, Kiyosawa K, Furuta S, Freni MA, Gerken G, Meyer zum Buschenfelde K-H: Demographics of anli-asialoglycoprotein receptor auloantibodies in autoimmune hepatitis. Gastroenterology 107:799-804, 1994
27. McFarlane BM, Sipos J, Gove CD, McFarlane IG, Williams R: Antibodies against the hepatic asialoglycoprolein receptor perfused in situ perferentially attach to periportal liver cell in the rat. Hepatology 11:408-415, 1990
28. Vento S, Hegarty JE, Boltazzo G, Macchia E, Williams R, Eddleston ALWF: Antigen specific suppressor cell function in autoimmune chronic active hepatitis. Lancet 1:1200-1204, 1984
29. O'Brien CJ, Vento S, Donaldson PT, McSorley CG, McFarlane IG, Williams R, Eddleston ALWF: Cell-mediated immunity and suppressor-T-cell defects to liver-derived antigens in families of patients with autoimmune chronic active hepatitis. Lancet 1:350-353, 1986
30. Vento S, O'Brien CJ, McFarlane IG, Williams R, Eddleston ALWF: T-cell inducers of suppressor lymphocytes control liver-directed autoreactivity. Lancet 1:886-888, 1987
31. Lohr H, Treichel U, Poralla T, Manns M, Meyer zum Buschenfelde K-H, Fleischer B: The human hepatic asialoglycoprotein receptor is a target for liver-infiltrating T cells in auto-immune chronic active hepatitis and primary biliary cirrhosis. Hcpatology 12:1314-1320, 1990
32. Lohr H, Treichel U, Poralla T, Manns M, Meyer zum Buschnfelde K-H, Fleischer B: Liver-infiltrating T helper cells stimulate the production of autoantibodies against the human asialoglycoprotein receptor in autoimmune chronic active hepatitis in vitro. Clin Exp Immunol 88:45-49, 1992
33. DiMagno EP, Corle D, O'Brien JF, Masnyk U, Go VLW, Aamodt R: Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum. Mayo Clin Proc 64:1226-1234, 1989
34. Czaja AJ, Carpenter HA: Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 105:1824-1832, 1993
35. Czaja AJ: Autoimmune hepatitis: current therapeutic concepts. Clin Immunother 1:413-429, 1994
36. McFarlane BM, McSorley CG, McFarlane IG, Williams R: A radioimmunoassay for detection of circulating antibodies reacting with the hepatic asialoglycoprotein receptor protein. J Immunol Methods 77:219-228, 1985
37. McFarlane IG, Hegarty JE, McSorley CO, McFarlane BM, Williams R: Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis. Lancet 2:954-956, 1984
38. McFarlane IG, McFarlane BM, Major GN, Tolley P, Williams R: Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP). Clin Exp Immunol 55:347-354, 1984
39. McFarlane BM, McSorley CG, Vergani D, McFarlane IG, Williams R: Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver diseases. J Hepatol 3:196-205, 1986
40. McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, Williams R: Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet 335:754-757, 1990
41. Esteban JI, Esteban R, Viladomiu L, Lopez-Talavera JC, Gonzalez A, Hernandez JM, Roget M, Vargas V, Guardia J, Houghton M, Choo Q-L, Kuo G: Hepatitis C virus antibodies among risk groups in Spain. Lancet 2:294-297, 1989
42. Solosvay RD, Summerskill WHJ, Baggenstoss AH, Schoenfield LJ: "Lupoid" hepatitis, a nonentity in the spectrum of chronic active liver disease. Gastroenterology 63:458-465, 1972